Macular degeneration case report

What makes this case noteworthy is the fact that this patient, who was homeless developed blindness in both eyes due to macular degeneration. This is due to the fact that he had no access to any sort of healthcare or even to basic resources such as proper shelter and food. This resulted in the deterioration of his overall health, including his eyes. If he had access to proper resources and healthcare, his severe macular degeneration could have been slowed or even prevented.

Content

Author and article information

Journal

Title: ScienceOpen Preprints

Publisher: ScienceOpen

Publication date (Electronic preprint): 6 September 2024

Affiliations

[1 ] Kansas City university ;

Author notes

[* ]Email: meshusingh@ 123456kansascity.edu .

Author information

Maneesh Singh https://orcid.org/0000-0003-4859-2546

Article

DOI: 10.14293/PR2199.001029.v1

SO-VID: a270bad9-7383-4559-9ccd-c30f76347d22

License:

This work has been published open access under Creative Commons Attribution License CC BY 4.0 , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Conditions, terms of use and publishing policy can be found at www.scienceopen.com .

History

Date received : 6 September 2024

References

Wong Wan Ling, Su Xinyi, Li Xiang, Cheung Chui Ming G, Klein Ronald, Cheng Ching-Yu, Wong Tien Yin. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health. Vol. 2(2)2014. Elsevier BV. [Cross Ref]
Tomany Sandra C., Wang Jie Jin, van Leeuwen Redmer, Klein Ronald, Mitchell Paul, Vingerling Johannes R., Klein Barbara E.K., Smith Wayne, de Jong Paulus T.V.M.. Risk factors for incident age-related macular degeneration. Ophthalmology. Vol. 111(7):1280–1287. 2004. Elsevier BV. [Cross Ref]
The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6. American Journal of Ophthalmology. Vol. 132(5):668–681. 2001. Elsevier BV. [Cross Ref]
Five-Year Follow-up of Fellow Eyes of Patients With Age-Related Macular Degeneration and Unilateral Extrafoveal Choroidal Neovascularization. Archives of Ophthalmology. Vol. 111(9)1993. American Medical Association (AMA). [Cross Ref]
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2. American Journal of Ophthalmology. Vol. 131(5):541–560. 2001. Elsevier BV. [Cross Ref]
D’Amico Donald J.. Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration. Ophthalmology. Vol. 113(6)2006. Elsevier BV. [Cross Ref]

Comments

Comment on this article

[1] Wong Wan Ling, Su Xinyi, Li Xiang, Cheung Chui Ming G, Klein Ronald, Cheng Ching-Yu, Wong Tien Yin. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. The Lancet Global Health. Vol. 2(2)2014. Elsevier BV. [Cross Ref]

[2] Tomany Sandra C., Wang Jie Jin, van Leeuwen Redmer, Klein Ronald, Mitchell Paul, Vingerling Johannes R., Klein Barbara E.K., Smith Wayne, de Jong Paulus T.V.M.. Risk factors for incident age-related macular degeneration. Ophthalmology. Vol. 111(7):1280–1287. 2004. Elsevier BV. [Cross Ref]

[3] The age-related eye disease study system for classifying age-related macular degeneration from stereoscopic color fundus photographs: the age-related eye disease study report number 6. American Journal of Ophthalmology. Vol. 132(5):668–681. 2001. Elsevier BV. [Cross Ref]

[4] Five-Year Follow-up of Fellow Eyes of Patients With Age-Related Macular Degeneration and Unilateral Extrafoveal Choroidal Neovascularization. Archives of Ophthalmology. Vol. 111(9)1993. American Medical Association (AMA). [Cross Ref]

[5] Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2. American Journal of Ophthalmology. Vol. 131(5):541–560. 2001. Elsevier BV. [Cross Ref]

[6] D’Amico Donald J.. Pegaptanib Sodium for Neovascular Age-Related Macular Degeneration. Ophthalmology. Vol. 113(6)2006. Elsevier BV. [Cross Ref]

One-Click Submission System Now Available for SO Preprints, learn more on how this works in our blog post and don't forget to check the video, too!